Aller au contenu

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS ESMO 2020

19 Septembre 2020 · 3 joursOnline, SpainOncologyEnglish
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS ESMO 2020
Online

About this congress

The ESMO Congress 2020 will take place from 18 to 22 September 2020, at the IFEMA – Feria de Madrid, Spain.The ESMO Congress is the most influential oncology platform in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world.  ESMO Congress 2020 will present the very latest advances in oncology and translate science into better cancer patient care.The ESMO Congress 2020 programme will be developed by a committee composed of more than 300 international experts under the leadership of Scientific Chair Prof John Haanen, NKI Amsterdam, Netherlands, a leading expert in the field of immunotherapy.ESMO invites all oncology stakeholders: researchers, clinicians, industry partners, patient advocates and members of the press to mark their calendars for ESMO Congress 2020 in Madrid.

MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.

Vidéos de ce congrès

OncLive News Network On Location: ESMO 2020 Day 3
Play the video · OncLive News Network On Location: ESMO 2020 Day 3Inscription gratuite requise pour lancer la lecture

00:44:29

OncLive News Network On Location: ESMO 2020 Day 1
Play the video · OncLive News Network On Location: ESMO 2020 Day 1Inscription gratuite requise pour lancer la lecture

00:38:53

Philip Jerman · ESMO 2020 Satellite Symposium: Philip Jermann - NTRK, RET and other fusion biomarkers testing
Play the video · Philip Jerman · ESMO 2020 Satellite Symposium: Philip Jermann - NTRK, RET and other fusion biomarkers testingInscription gratuite requise pour lancer la lecture

Philip Jerman · 00:12:53

Christophe Borg · ESMO 2020 Highlights on neoadjuvant mFOLFIRINOX for T3-4 rectal cancer: The PRODIGE 23 study
Play the video · Christophe Borg · ESMO 2020 Highlights on neoadjuvant mFOLFIRINOX for T3-4 rectal cancer: The PRODIGE 23 studyInscription gratuite requise pour lancer la lecture

Christophe Borg · 00:02:44

Ajjai Alva · ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 study
Play the video · Ajjai Alva · ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 studyInscription gratuite requise pour lancer la lecture

Ajjai Alva · 00:03:20

David Hong · ESMO 2020 Highlights on durability of clinical benefit and biomarkers with AMG510 in NSCLC
Play the video · David Hong · ESMO 2020 Highlights on durability of clinical benefit and biomarkers with AMG510 in NSCLCInscription gratuite requise pour lancer la lecture

David Hong · 00:03:03

Daniel Renouf · ESMO 2020 Highlights on 1st line durvalumab and tremelimumab for mPDAC: The PA.7 study
Play the video · Daniel Renouf · ESMO 2020 Highlights on 1st line durvalumab and tremelimumab for mPDAC: The PA.7 studyInscription gratuite requise pour lancer la lecture

Daniel Renouf · 00:03:54

Toni Choueiri · ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER study
Play the video · Toni Choueiri · ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER studyInscription gratuite requise pour lancer la lecture

Toni Choueiri · 00:02:04

Solange Peters · ESMO Virtual Congress 2020
Play the video · Solange Peters · ESMO Virtual Congress 2020Inscription gratuite requise pour lancer la lecture

Solange Peters · 00:01:55

ESMO Virtual Congress 2020: anticipations on practice-changing results in gastric cancers
Play the video · ESMO Virtual Congress 2020: anticipations on practice-changing results in gastric cancersInscription gratuite requise pour lancer la lecture

00:04:52

Johann de Bono · ESMO 2020 Highlights on blocking PI3K/AKT signalling pathway in mCRPC: The IPATential150 study
Play the video · Johann de Bono · ESMO 2020 Highlights on blocking PI3K/AKT signalling pathway in mCRPC: The IPATential150 studyInscription gratuite requise pour lancer la lecture

Johann de Bono · 00:03:06

Zarnie Lwin · ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005
Play the video · Zarnie Lwin · ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005Inscription gratuite requise pour lancer la lecture

Zarnie Lwin · 00:02:56